Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Interest Expenses (2016 - 2024)

Fortress Biotech has reported Interest Expenses over the past 9 years, most recently at $100000.0 for Q2 2024.

  • Quarterly results put Interest Expenses at $100000.0 for Q2 2024, changed 0.0% from a year ago — trailing twelve months through Mar 2025 was $100000.0 (down 75.0% YoY), and the annual figure for FY2024 was $100000.0, down 66.67%.
  • Interest Expenses for Q2 2024 was $100000.0 at Fortress Biotech, roughly flat from $100000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for FBIO hit a ceiling of $400000.0 in Q3 2021 and a floor of $100000.0 in Q2 2023.
  • Median Interest Expenses over the past 3 years was $100000.0 (2023), compared with a mean of $150000.0.
  • Peak annual rise in Interest Expenses hit 0.0% in 2024, while the deepest fall reached 0.0% in 2024.
  • Fortress Biotech's Interest Expenses stood at $400000.0 in 2021, then crashed by 75.0% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024.
  • The last three reported values for Interest Expenses were $100000.0 (Q2 2024), $100000.0 (Q1 2024), and $100000.0 (Q4 2023) per Business Quant data.